Testing effectiveness (Phase 2)Ended earlyNCT05282121
What this trial is testing
Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)
Who this might be right for
Liver DiseasesHypertension, Portal
Boehringer Ingelheim 90